MAR-FLECAINIDE 100 MG
FLECAINIDE ACETATE : 100 MG · DIN 02476185 · MARCAN PHARMACEUTICALS INC
Health Canada status: DORMANT
What is MAR-FLECAINIDE?
MAR-FLECAINIDE 100 MG contains FLECAINIDE ACETATE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02476185, held by MARCAN PHARMACEUTICALS INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as dormant, status dated 17-Jan-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02476185 |
|---|---|
| Brand name | MAR-FLECAINIDE |
| Generic / active ingredient | FLECAINIDE ACETATE : 100 MG |
| Manufacturer | MARCAN PHARMACEUTICALS INC |
| Strength | 100 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C01BC04 FLECAINIDE |
| AHFS class | 68:20.04 ; 68:20.18 |
| Biosimilar | No |
| Health Canada status | DORMANT |
| Status date | 17-Jan-2024 |
| Original market date | 2018-07-06 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code C01BC04 FLECAINIDE. 10 of 16 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-FLECAINIDE | 100 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02516071 |
| AG-FLECAINIDE | 50 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02516063 |
| APO-FLECAINIDE | 100 MG | TABLET | APOTEX INC | MARKETED | DIN 02275546 |
| APO-FLECAINIDE | 50 MG | TABLET | APOTEX INC | MARKETED | DIN 02275538 |
| AURO-FLECAINIDE | 100 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02459965 |
| AURO-FLECAINIDE | 50 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02459957 |
| FLECAINIDE | 100 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02534819 |
| FLECAINIDE | 50 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02534800 |
| JAMP FLECAINIDE | 100 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02493713 |
| JAMP FLECAINIDE | 50 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02493705 |
Who else supplies FLECAINIDE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FLECAINIDE appears in 83 registered pack listings across 9 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.